Pharvaris (PHVS) Depreciation and Depletion (2020 - 2026)

Pharvaris (PHVS) has 7 years of Depreciation and Depletion data on file, last reported at $122607.5 in Q1 2026.

• Quarterly Depreciation and Depletion rose 10.69% year-over-year to $122607.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $484235.0 (up 46.84% YoY) and the FY2025 annual result came in at $472659.9, up 62.0% from the prior year.
• Depreciation and Depletion steadied at $122607.5 in Q1 2026, from $122070.9 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $122928.5 in Q3 2025 to a low of -$134.5 billion in Q3 2023.
• A 5-year average of -$7.9 billion and a median of $71038.9 in 2023 frame the typical range for Depreciation and Depletion.
• Annual changes were most pronounced in 2022 — Depreciation and Depletion surged 898.53% — and 2023, when it plunged 345944944.87%.
• Tracing PHVS's Depreciation and Depletion over 5 years: stood at $47108.9 in 2022, then surged by 50.8% to $71038.9 in 2023, then jumped by 36.82% to $97197.3 in 2024, then grew by 25.59% to $122070.9 in 2025, then climbed by 0.44% to $122607.5 in 2026.
• The last three Depreciation and Depletion figures came in at $122607.5 (Q1 2026), $122070.9 (Q4 2025), and $122928.5 (Q3 2025), per Business Quant data.